Biogen Inc. Share Price & Technical Analysis
BIIB · $193.8 (+2.26%)
Healthcare / Drug Manufacturers - General
$193.8
+2.26%
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasi…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
0% return in May, 3% avg return in past 3 year May month.
9% return in 2026, -12% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 3% | 7% | -4% | 3% | 0% | – | – | – | – | – | – | – | 9% |
| 25 | -6% | -2% | -3% | -11% | 8% | -3% | 2% | 2% | 5% | 10% | 19% | -2% | 18% |
| 24 | -4% | -12% | -1% | 0% | 4% | 3% | -8% | -5% | -5% | -11% | -7% | -5% | -51% |
| 23 | 5% | -7% | 4% | 10% | -3% | -5% | -4% | -1% | -4% | -7% | -2% | 11% | -4% |
| 22 | -6% | -7% | 0% | -2% | -3% | 1% | 5% | -9% | 37% | 5% | 8% | -9% | 19% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Uptrend
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE. It offers LEQEMBI for the treatment of Alzheimer's disease; ZURZUVAE for the treatment of postpartum depression; RITUXAN to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; OCREVUS for relapsing MS and primary progressive MS; LUNSUMIO to treat relapsed or refractory follicular lymphoma; glofitamab for aRelapsed or refractory diffuse large B-cell lymphoma; and other anti-CD20 therapies. Biogen Inc. has collaboration and license agreements with Merz Therapeutics; Alkermes Pharma Ireland Limited; Denali Therapeutics Inc.; UCB; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; Ionis Pharmaceuticals, Inc.; Samsung Bioepis; and Sage Therapeutics, Inc., as well as collaborations with Stoke Therapeutics, Inc. for the development and commercialization of zorevunersen, a disease modifying medicine for the treatment of Dravet syndrome; Dayra Therapeutics, Inc. to develop oral macrocyclic peptides; Vanqua Bio, Inc. for developing Vanqua's preclinical oral C5aR1 antagonist compound; City Therapeutics, Inc. to develop select novel RNAi therapies; and ALTEOGEN Inc. to develop subcutaneous (SC) formulations of biologics utilizing ALT-B4. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$29.44B
P/E ratio
21.44
52W high
$206.0
52W low
$121.1
Volume
7,95,597
Beta
0.20
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Biogen Inc. share price today?
- Biogen Inc. (BIIB) last traded around $193.8 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BIIB have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BIIB. Download the app for real-time alerts.
- How can I analyze Biogen Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.